Date: Saturday, September 14th 2024
Time:  07:00 AM – 3:30 PM
Location: Houston Marriott Medical Center/Museum District 6580 Fannin Street, Houston, TX 77030.
Parking: Self-parking for a fee (located at 6560 Fannin Street, Houston, Texas 77030)

Conference Objectives:
1. Discuss the latest treatment modalities and protocols for selected cancer, including advancements in targeted therapies and immunotherapies.
2. Integrate personalized medicine approaches and biomarker testing in the management of oncology patients, focusing on how these strategies can improve outcomes and tailor treatments for selected cancers
3.  Evaluate the integration of AI in cancer care 

CNE Statement/Available Credit 

AMA PRA Category  
The University of Texas Medical Branch is accredited by the Accreditation Council for Continuing Medical 
Education (ACCME) to provide continuing medical education for physicians. 
The University of Texas Medical Branch designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

ANCC Credit

Contact hours: 6.5 including 1.75 Pharmacology hour

This nursing continuing professional development activity was approved by Louisiana State Nurses Association - Approver, an accredited approver by the American Nurses Credentialing
Center’s Commission on Accreditation.

REQUIREMENTS FOR SUCCESSFUL COMPLETION:

Learning outcomes: 100% of nurses and other participants will gain knowledge that is current and use best practices related to care and management of different malignancies and will score on average 80% correct answers captured in the Slido (live polls and quizzes) exercises. 

To receive contact hours for this nursing continuing professional development activity, the participant must:
• Attend and be present for the entire presentation either in-person or virtually via Zoom. No partial credit will be provided. 
• Complete the evaluation after the presentation via a link provided to all participants.  
• Certificates will be awarded electronically upon completion of the evaluation.

Once successful completion has been verified, a “Certificate of Successful Completion” will be awarded for 6.5 NCPD contact hours and 1.75 Pharmacotherapeutic contact hours.

None of the planners, and speakers/presenters for this activity have relevant financial relationship(s) to disclose with ineligible companies.
No relevant financial relationships were identified for any other individuals with the ability to control the content of the activity.

Faculty/Speakers

Planners

Maribel M. Marquez-Bhojani, DNP, RN, NPD-BC - Nurse Planner, Nothing to Disclose
Samina Asfandiyar DNP, APRN, FNP-C, CEN - Planning Team, Nothing to Disclose
Allegra Baccinelli, MSN, RN - Planning Team, Nothing to Disclose
Meghan Jones, MSN, RN, OCN, NPD-BC - Planning Team, Nothing to Disclose
Roselyn Ogunkunle PhD, MSN, RN, NEA-BC, OCN - Planning Team, Nothing to Disclose

To exhibit at this program, please email info@daaronfoundation.org
All industry partners attending as attendees must register to attend and abide by all applicable compliance regulations

Thank you!

Sponsor

Daiichi Sankyo, Inc

Podium Sponsors

AbbVie       Sobi          Jazz Pharmaceuticals

Exhibitors

                 Bayer                                  Daiichi Sankyo, Inc

Ipsen                                     Merck

                        Pfizer                          PCYC                                 Pharmacosmos Therapeutics Inc

Syndax                                 Taiho Oncology, Inc.                                         Takeda Oncology